dimethyl sulfoxide has been researched along with Arteriovenous Malformations, Cerebral in 135 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Onyx, an ethylene-vinyl alcohol copolymer mixed in a dimethyl sulfoxide solvent, is currently one of the most widely used liquid materials for embolization of intracranial arteriovenous malformations (AVMs)." | 3.81 | Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study. ( Ball, B; Chen, CJ; Lee, CC; Schlesinger, D; Sheehan, J; Xu, Z; Yen, CP, 2015) |
| "No patient suffered recurrent intracranial hemorrhage during follow-up." | 2.82 | Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas Presenting with Intracranial Hemorrhage in 46 Consecutive Patients: With Emphasis on Transarterial Embolization with Onyx. ( Jiang, C; Li, C; Li, Y; Wu, Z; Yang, X, 2016) |
| "We report our experiences in the treatment of intracranial arteriovenous malformations (AVMs) with Onyx embolization before neuro- or radiosurgery, focusing on the embolization technique with Onyx." | 2.73 | Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. ( Kis, B; Kuehne, D; Siekmann, R; Weber, W, 2007) |
| "DAVFs (dural arteriovenous fistulas) represent one of the most dangerous types of intracranial AV shunts." | 2.73 | Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx. ( Cognard, C; Januel, AC; Silva, NA; Tall, P, 2008) |
| "Endovascular embolization of cerebral arteriovenous malformations (AVMs) originally entailed delivery of N-butyl cyanoacrylate glue to the nidus via a flow-directed microcatheter." | 2.66 | Embolic Agents and Microcatheters for Endovascular Treatment of Cerebral Arteriovenous Malformations. ( Lara-Reyna, J; Schupper, AJ; Triano, MJ; Yaeger, KA, 2020) |
| "Congenital brain arteriovenous fistulas (BAVFs) are rare neurovascular lesions of the brain, and few cases have been reported of their treatment with a combination of detachable coils and Onyx, especially in infants." | 2.52 | Endovascular Treatment of Two High-Flow Brain Arteriovenous Fistulas with a Combination of Detachable Coils and Onyx in an Infant: Case Report and Review of Literature. ( Li, Z; Quan, Z; Wang, Q, 2015) |
| "Endovascular occlusion of cerebral arteriovenous malformations (AVM) is often utilized as adjunctive therapy in combination with radiosurgery or microsurgery." | 2.50 | Embolization-induced angiogenesis in cerebral arteriovenous malformations. ( Buell, TJ; Ding, D; Liu, KC; Starke, RM; Webster Crowley, R, 2014) |
| "It was found that Onyx embolization is safe and represents a good option for an initial treatment approach, in a sequential treatment strategy for pediatric ruptured brain AVMs." | 1.62 | First Line Onyx Embolization in Ruptured Pediatric Arteriovenous Malformations : Safety and Efficacy. ( Alias, Q; Beccaria, K; Benichi, S; Blauwblomme, T; Boddaert, N; Boulouis, G; Brunelle, F; Gariel, F; Garzelli, L; Kossorotoff, M; Meyer, P; Naggara, O, 2021) |
| " The primary endpoint was any catheter-related adverse event (AE) at 30 days, such as unintentional tip detachment or malfunction with clinical sequelae, or retained catheter." | 1.62 | Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study. ( Aziz-Sultan, MA; Bellon, RJ; Chitale, RV; Cockroft, KM; Deshmukh, VR; Diaz, O; Fifi, JT; Fiorella, D; Given, CA; Gonzalez, LF; Hanel, RA; Huddle, D; Jagadeesan, BD; Kan, P; Kvamme, P; Meyers, PM; Miller, TR; Mokin, M; Morrow, JT; Polifka, AJ; Puri, AS; Seinfeld, J; Singer, J; Wakhloo, AK; Woo, HH; Yao, TL; Zomorodi, AR, 2021) |
| "Transarterial coil embolization of the ruptured aneurysm and partial Onyx embolization of the shunt led to thrombosis of the aneurysm." | 1.56 | Transvenous embolization for craniocervical junction epidural arteriovenous fistula with a pial feeder aneurysm. ( Inoue, T; Kuwamoto, K; Mochizuki, T; Niimi, Y; Okada, Y; Ryu, B; Sato, S; Shima, S; Yoshida, K, 2020) |
| "Ethmoidal dural arteriovenous fistulas (eDAVFs) are an unusual type of intracranial vascular lesion that commonly present with acute haemorrhage." | 1.56 | A Case Series of Ethmoidal Dural Arteriovenous Fistulas Treated by Endovascular Embolization with Onyx. ( Christine, JA; Christophe, C; Duc, NM; Ha, HD, 2020) |
| "Twenty-seven patients with cerebral arteriovenous malformations were included." | 1.51 | Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations. ( Gorbatykh, A; Hristov, H; Karakostov, V; Kislitsin, D; Minkin, K; Ninov, K; Orlov, K; Penkov, M; Raychev, R; Sirakov, A; Sirakov, SS, 2019) |
| "Treatment of cerebral arteriovenous malformations (AVM)-the most common cause of stroke in the pediatric population-can be challenging due to the complexity of size, morphology, and location." | 1.48 | Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM. ( Constantini, S; Corn, BW; Frolov, V; Kanner, AA; Maimon, S; Shtraus, N; Strauss, I; Umansky, D, 2018) |
| "Conventional Onyx embolization of cerebral arteriovenous malformations (AVMs) requires lengthy procedure and fluoroscopy times to form an adequate 'proximal plug' which allows forward nidal penetration while preventing reflux and non-targeted embolization." | 1.42 | Balloon-augmented Onyx embolization of cerebral arteriovenous malformations using a dual-lumen balloon: a multicenter experience. ( Bhalla, T; Chaudry, MI; Delaney, JJ; James, RF; Janjua, RM; Lowe, SR; Quintero-Wolfe, S; Spiotta, AM; Turk, AS; Turner, RD; Vargas, J, 2015) |
| "Brain AVMs are a rare cause of cerebral hemorrhage and SAH, and their treatment is still debated." | 1.39 | Endovascular treatment of deep hemorrhagic brain arteriovenous malformations with transvenous onyx embolization. ( Consoli, A; Limbucci, N; Mangiafico, S; Nappini, S; Renieri, L, 2013) |
| "We present our results of endovascular treatment of ruptured AVMs in the acute phase." | 1.38 | Endovascular treatment of ruptured brain AVMs in the acute phase of hemorrhage. ( Beute, GN; Jacobs, S; Sluzewski, M; van der Pol, B; van Rooij, WJ, 2012) |
| "Onyx embolization of cerebral arteriovenous malformations (AVM) has become increasingly common." | 1.37 | Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation. ( Bederson, JB; de Los Reyes, K; Doshi, A; Egorova, N; Frontera, JA; Panov, F; Patel, A, 2011) |
| "Congenital brain arteriovenous fistulas (BAVFs) are rare vascular lesions, and conservative management was associated with a high mortality rate." | 1.36 | Endovascular treatment of congenital brain arteriovenous fistulas with combination of detachable coils and onyx liquid embolic agent. ( Chen, G; Leng, B; Song, D; Wang, Q; Wang, X, 2010) |
| "Onyx embolisation of cerebral arteriovenous malformations is feasible in Hong Kong." | 1.35 | Use of Onyx (a patented ethylene-vinyl alcohol copolymer formulation) embolisation of cerebral arteriovenous malformations in Hong Kong: initial experience. ( Kam, MK; Poon, WS; Wong, GK; Yu, SC; Zhu, XL, 2009) |
| " Nine adverse events occurred in 7 patients during 8 procedures (16%), one causing a permanent deficit." | 1.33 | Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging. ( Brandt, L; Cronqvist, M; Holtås, S; Larsson, EM; Nilsson, O; Ramgren, B; Romner, B; Säveland, H; Wirestam, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.74) | 18.2507 |
| 2000's | 43 (31.85) | 29.6817 |
| 2010's | 72 (53.33) | 24.3611 |
| 2020's | 19 (14.07) | 2.80 |
| Authors | Studies |
|---|---|
| Cortese, J | 1 |
| Coskun, O | 1 |
| Di Maria, F | 1 |
| Pizzuto, S | 1 |
| Rodesch, G | 1 |
| Consoli, A | 2 |
| Schmitt, N | 3 |
| Wucherpfennig, L | 2 |
| Hohenstatt, S | 2 |
| Weyland, CS | 1 |
| Sommer, CM | 3 |
| Bendszus, M | 7 |
| Möhlenbruch, MA | 6 |
| Vollherbst, DF | 6 |
| Satti, SR | 1 |
| Fan, X | 1 |
| Kottenmeier, E | 1 |
| Khanna, R | 1 |
| Rai, AT | 1 |
| Giurazza, F | 1 |
| Cionfoli, N | 1 |
| Paladini, A | 1 |
| Vallone, M | 1 |
| Corvino, F | 1 |
| Teodoli, L | 1 |
| Moramarco, L | 1 |
| Quaretti, P | 1 |
| Catalano, C | 1 |
| Niola, R | 1 |
| Lucatelli, P | 1 |
| Karimian-Jazi, K | 1 |
| Breckwoldt, MO | 1 |
| Kauczor, HU | 2 |
| Nussbaum, BR | 1 |
| Graupman, P | 1 |
| Torok, CM | 1 |
| Yesavage, TA | 1 |
| Nussbaum, ES | 1 |
| Yoshida, K | 1 |
| Sato, S | 1 |
| Inoue, T | 1 |
| Ryu, B | 1 |
| Shima, S | 1 |
| Mochizuki, T | 1 |
| Kuwamoto, K | 1 |
| Okada, Y | 1 |
| Niimi, Y | 2 |
| Peng, G | 1 |
| Yang, CX | 1 |
| Liu, H | 1 |
| Shen, C | 1 |
| Alias, Q | 1 |
| Boulouis, G | 1 |
| Blauwblomme, T | 1 |
| Benichi, S | 1 |
| Beccaria, K | 1 |
| Gariel, F | 1 |
| Garzelli, L | 1 |
| Meyer, P | 1 |
| Kossorotoff, M | 1 |
| Boddaert, N | 1 |
| Brunelle, F | 1 |
| Naggara, O | 1 |
| Desai, VR | 1 |
| Lee, JJ | 1 |
| Tomas, J | 1 |
| Lumsden, A | 1 |
| Britz, GW | 3 |
| Brahimaj, BC | 1 |
| Keigher, K | 1 |
| Lopes, DK | 1 |
| Sirakov, A | 3 |
| Minkin, K | 3 |
| Sirakov, S | 2 |
| Ha, HD | 1 |
| Duc, NM | 1 |
| Christine, JA | 1 |
| Christophe, C | 1 |
| Triano, MJ | 1 |
| Lara-Reyna, J | 1 |
| Schupper, AJ | 1 |
| Yaeger, KA | 1 |
| Matanov, S | 1 |
| Meyers, PM | 1 |
| Fifi, JT | 1 |
| Cockroft, KM | 1 |
| Miller, TR | 1 |
| Given, CA | 1 |
| Zomorodi, AR | 1 |
| Jagadeesan, BD | 1 |
| Mokin, M | 1 |
| Kan, P | 2 |
| Yao, TL | 1 |
| Diaz, O | 1 |
| Huddle, D | 1 |
| Bellon, RJ | 1 |
| Seinfeld, J | 1 |
| Polifka, AJ | 1 |
| Fiorella, D | 1 |
| Chitale, RV | 1 |
| Kvamme, P | 1 |
| Morrow, JT | 1 |
| Singer, J | 1 |
| Wakhloo, AK | 1 |
| Puri, AS | 1 |
| Deshmukh, VR | 1 |
| Hanel, RA | 1 |
| Gonzalez, LF | 1 |
| Woo, HH | 1 |
| Aziz-Sultan, MA | 2 |
| Wagner, KM | 1 |
| Srinivasan, VM | 1 |
| Floca, RO | 1 |
| Paech, D | 1 |
| El Shafie, RA | 1 |
| Neuberger, U | 1 |
| Chapot, R | 3 |
| Ulfert, C | 2 |
| Pfaff, J | 2 |
| Lv, X | 7 |
| Hu, X | 1 |
| Li, W | 2 |
| He, H | 2 |
| Jiang, C | 5 |
| Li, Y | 7 |
| Gungor, D | 1 |
| Oğuz, Ş | 1 |
| Dinc, H | 1 |
| Jin, H | 1 |
| Liu, Z | 1 |
| Chang, Q | 1 |
| Chen, C | 1 |
| Ge, H | 1 |
| Otto, R | 1 |
| von Deimling, A | 1 |
| Nerva, JD | 1 |
| Barber, J | 1 |
| Levitt, MR | 1 |
| Rockhill, JK | 1 |
| Hallam, DK | 2 |
| Ghodke, BV | 2 |
| Sekhar, LN | 3 |
| Kim, LJ | 2 |
| Flores, BC | 1 |
| See, AP | 1 |
| Weiner, GM | 1 |
| Jankowitz, BT | 2 |
| Ducruet, AF | 2 |
| Albuquerque, FC | 2 |
| Umansky, D | 1 |
| Corn, BW | 1 |
| Strauss, I | 2 |
| Shtraus, N | 1 |
| Constantini, S | 1 |
| Frolov, V | 2 |
| Maimon, S | 2 |
| Kanner, AA | 1 |
| Sirakov, SS | 1 |
| Hristov, H | 1 |
| Ninov, K | 1 |
| Penkov, M | 1 |
| Karakostov, V | 1 |
| Orlov, K | 1 |
| Gorbatykh, A | 1 |
| Kislitsin, D | 1 |
| Raychev, R | 1 |
| Zhang, B | 1 |
| Feng, X | 1 |
| Peng, F | 1 |
| Wang, L | 1 |
| Guo, EK | 1 |
| Zhang, Y | 1 |
| Liu, P | 1 |
| Wu, Z | 6 |
| Liu, A | 2 |
| Sun, Y | 2 |
| Li, X | 1 |
| Xiong, J | 1 |
| Yu, J | 1 |
| Gesheva, S | 1 |
| Couldwell, WT | 1 |
| Mortimer, V | 1 |
| Taussky, P | 1 |
| Grandhi, R | 1 |
| Trivelato, FP | 1 |
| Manzato, LB | 1 |
| Rezende, MT | 1 |
| Ulhôa, AC | 1 |
| Martínez-Galdámez, M | 2 |
| Saura, P | 2 |
| Saura, J | 2 |
| Muñiz, J | 2 |
| Albisua, J | 2 |
| Pérez-Higueras, A | 2 |
| Renieri, L | 1 |
| Nappini, S | 1 |
| Limbucci, N | 1 |
| Mangiafico, S | 1 |
| Feng, W | 1 |
| Zhang, L | 1 |
| Zhang, G | 2 |
| He, X | 1 |
| Wang, G | 1 |
| Li, M | 1 |
| Qi, S | 1 |
| Pierot, L | 3 |
| Cognard, C | 3 |
| Herbreteau, D | 3 |
| Fransen, H | 1 |
| van Rooij, WJ | 4 |
| Boccardi, E | 1 |
| Beltramello, A | 1 |
| Sourour, N | 2 |
| Kupcs, K | 1 |
| Biondi, A | 1 |
| Bonafé, A | 1 |
| Reith, W | 1 |
| Casasco, A | 2 |
| Jalaly, J | 1 |
| Dalfino, J | 1 |
| Mousa, SA | 1 |
| Kondo, R | 1 |
| Matsumoto, Y | 1 |
| Endo, H | 1 |
| Miyachi, S | 1 |
| Ezura, M | 1 |
| Sakai, N | 2 |
| Stracke, P | 1 |
| Velasco, A | 1 |
| Nordmeyer, H | 1 |
| Heddier, M | 1 |
| Stauder, M | 1 |
| Schooss, P | 1 |
| Mosimann, PJ | 1 |
| Haussen, DC | 1 |
| Ashour, R | 1 |
| Johnson, JN | 1 |
| Elhammady, MS | 1 |
| Peterson, EC | 1 |
| Cesar, L | 1 |
| Bowie, C | 1 |
| Buell, TJ | 1 |
| Ding, D | 1 |
| Starke, RM | 1 |
| Webster Crowley, R | 1 |
| Liu, KC | 1 |
| Spiotta, AM | 1 |
| James, RF | 1 |
| Lowe, SR | 1 |
| Vargas, J | 1 |
| Turk, AS | 1 |
| Chaudry, MI | 1 |
| Bhalla, T | 1 |
| Janjua, RM | 1 |
| Delaney, JJ | 1 |
| Quintero-Wolfe, S | 1 |
| Turner, RD | 1 |
| Li, C | 1 |
| Yang, X | 3 |
| Elsenousi, A | 1 |
| Aletich, VA | 1 |
| Alaraj, A | 1 |
| Lee, CC | 1 |
| Chen, CJ | 1 |
| Ball, B | 1 |
| Schlesinger, D | 1 |
| Xu, Z | 1 |
| Yen, CP | 1 |
| Sheehan, J | 1 |
| Wen, J | 1 |
| Duan, CZ | 1 |
| Huang, LJ | 1 |
| Zhang, X | 1 |
| He, XY | 1 |
| Li, XF | 1 |
| Crowley, RW | 2 |
| Kalani, MY | 1 |
| McDougall, CG | 2 |
| Zipfel, GJ | 1 |
| Senturk, C | 1 |
| Leyon, JJ | 1 |
| Chavda, S | 2 |
| Thomas, A | 2 |
| Lamin, S | 2 |
| Bauer, AM | 1 |
| Bain, MD | 1 |
| Rasmussen, PA | 1 |
| Deshaies, EM | 1 |
| Singla, A | 1 |
| Allott, G | 1 |
| Villwock, MR | 1 |
| Li, F | 1 |
| Gorji, R | 1 |
| Wang, Q | 2 |
| Quan, Z | 1 |
| Li, Z | 1 |
| Klimo, P | 1 |
| Nesvick, CL | 1 |
| Kim, B | 1 |
| Jeon, P | 1 |
| Kim, K | 1 |
| Kim, S | 1 |
| Kim, H | 2 |
| Byun, HS | 1 |
| Jo, KI | 1 |
| Shimoda, Y | 1 |
| Osanai, T | 1 |
| Nakayama, N | 1 |
| Ushikoshi, S | 1 |
| Hokari, M | 1 |
| Shichinohe, H | 1 |
| Abumiya, T | 1 |
| Kazumata, K | 1 |
| Houkin, K | 1 |
| de Castro-Afonso, LH | 2 |
| Nakiri, GS | 4 |
| Oliveira, RS | 1 |
| Santos, MV | 1 |
| Santos, ACD | 1 |
| Machado, HR | 1 |
| Abud, DG | 4 |
| Monsignore, LM | 1 |
| Colli, BO | 1 |
| Alexander, MD | 1 |
| Cooke, DL | 1 |
| Hetts, SW | 1 |
| Ikeda, H | 1 |
| Imamura, H | 1 |
| Agawa, Y | 1 |
| Imai, Y | 1 |
| Tani, S | 1 |
| Adachi, H | 1 |
| Ishikawa, T | 1 |
| Mineharu, Y | 1 |
| Zhu, S | 1 |
| Wu, P | 1 |
| Xu, S | 1 |
| Shi, H | 1 |
| Chew, HS | 1 |
| Piano, M | 1 |
| Quilici, L | 1 |
| Pero, G | 1 |
| Holtmannspolter, M | 1 |
| Cronqvist, ME | 1 |
| Guimaraens, L | 1 |
| Paul, L | 1 |
| Gil Garcia, A | 1 |
| Aleu, A | 1 |
| Tolly, BT | 1 |
| Kosky, JL | 1 |
| Koht, A | 1 |
| Hemmer, LB | 1 |
| Velat, GJ | 1 |
| Reavey-Cantwell, JF | 1 |
| Sistrom, C | 1 |
| Smullen, D | 1 |
| Fautheree, GL | 1 |
| Whiting, J | 1 |
| Lewis, SB | 1 |
| Mericle, RA | 2 |
| Firment, CS | 1 |
| Hoh, BL | 1 |
| Vora, N | 1 |
| Jovin, T | 1 |
| Horowitz, M | 1 |
| Natarajan, SK | 2 |
| Ghodke, B | 2 |
| Born, DE | 1 |
| Panagiotopoulos, V | 2 |
| Gizewski, E | 1 |
| Asgari, S | 2 |
| Regel, J | 1 |
| Forsting, M | 2 |
| Wanke, I | 2 |
| Hammami, N | 2 |
| Ben Yaacoub, I | 1 |
| Nagi, S | 1 |
| Drissi, C | 1 |
| Sebai, R | 1 |
| Ben Hamouda, M | 1 |
| Jayaraman, M | 1 |
| Cloft, HJ | 1 |
| Möller-Hartmann, W | 1 |
| Sandalcioglu, IE | 1 |
| Hauck, EF | 1 |
| Welch, BG | 1 |
| White, JA | 1 |
| Purdy, PD | 1 |
| Pride, LG | 1 |
| Samson, D | 1 |
| Li, XS | 1 |
| Qi, TW | 2 |
| Guo, SL | 1 |
| Shi, ZS | 5 |
| Huang, ZS | 2 |
| Liang, F | 1 |
| Jiang, XB | 1 |
| Katsaridis, V | 4 |
| Papagiannaki, C | 2 |
| Aimar, E | 2 |
| Januel, AC | 2 |
| Barreau, X | 1 |
| Drouineau, J | 1 |
| Berge, J | 1 |
| Loh, Y | 3 |
| Duckwiler, GR | 4 |
| Jahan, R | 4 |
| Viñuela, F | 5 |
| Born, D | 1 |
| Loy, DN | 1 |
| Rich, KM | 2 |
| Simpson, J | 1 |
| Dorward, I | 1 |
| Santanam, L | 1 |
| Derdeyn, CP | 2 |
| Asouhidou, I | 2 |
| Georgiadis, G | 2 |
| Lesley, WS | 1 |
| Steiger, HJ | 1 |
| Hänggi, D | 1 |
| Wong, GK | 1 |
| Yu, SC | 1 |
| Zhu, XL | 1 |
| Kam, MK | 1 |
| Poon, WS | 1 |
| Margalit, N | 1 |
| Ram, Z | 1 |
| Wang, X | 1 |
| Chen, G | 1 |
| Leng, B | 4 |
| Song, D | 2 |
| Liu, L | 1 |
| Lanzino, G | 1 |
| Cloft, H | 1 |
| Meng, L | 1 |
| Zilianaki, D | 1 |
| Vaidis, G | 1 |
| Ioannou, P | 1 |
| Riva, R | 1 |
| Padovani, F | 1 |
| Khawaldeh, M | 1 |
| Mounayer, C | 3 |
| Xu, F | 1 |
| Ni, W | 1 |
| Liao, Y | 1 |
| Gu, Y | 1 |
| Xu, B | 2 |
| Zhang, N | 1 |
| Mamalui-Hunter, M | 1 |
| Jiang, T | 1 |
| Drzymala, RE | 1 |
| Walcott, BP | 1 |
| Gerrard, JL | 1 |
| Nogueira, RG | 3 |
| Nahed, BV | 1 |
| Terry, AR | 1 |
| Ogilvy, CS | 3 |
| de Los Reyes, K | 1 |
| Patel, A | 1 |
| Doshi, A | 1 |
| Egorova, N | 1 |
| Panov, F | 1 |
| Bederson, JB | 1 |
| Frontera, JA | 1 |
| Fifi, J | 1 |
| Berenstein, A | 1 |
| Jacobs, S | 2 |
| Sluzewski, M | 3 |
| Beute, GN | 3 |
| van der Pol, B | 2 |
| Sprengers, ME | 1 |
| Rabinov, JD | 2 |
| Yoo, AJ | 2 |
| Carter, BS | 1 |
| Hirsch, JA | 3 |
| Möhlenbruch, M | 1 |
| Rohde, S | 1 |
| Gonzalez, N | 1 |
| Tateshima, S | 2 |
| Feng, L | 2 |
| Duckwiler, G | 2 |
| Abud, TG | 1 |
| Orozco, LD | 1 |
| Luzardo, GD | 1 |
| Buciuc, RF | 1 |
| Poncyljusz, W | 1 |
| Falkowski, A | 1 |
| Rać, M | 1 |
| Sagan, L | 1 |
| Kojder, I | 1 |
| Bayrlee, A | 1 |
| Copen, WA | 1 |
| Kadziolka, K | 1 |
| Litré, F | 1 |
| Rousseaux, P | 1 |
| Soltanolkotabi, M | 1 |
| Schoeneman, SE | 1 |
| Alden, TD | 1 |
| Hurley, MC | 1 |
| Ansari, SA | 1 |
| DiPatri, AJ | 1 |
| Tomita, T | 1 |
| Shaibani, A | 1 |
| Lagares, A | 1 |
| Lobato, RD | 1 |
| Ricoy, JR | 1 |
| Campollo, J | 1 |
| Pelz, DM | 1 |
| Song, DL | 2 |
| Zhou, LF | 2 |
| Gu, YX | 1 |
| Chen, XC | 2 |
| Howington, JU | 1 |
| Kerber, CW | 1 |
| Hopkins, LN | 1 |
| Al-Shahi, R | 1 |
| Warlow, C | 1 |
| Cronqvist, M | 1 |
| Wirestam, R | 1 |
| Ramgren, B | 1 |
| Brandt, L | 1 |
| Romner, B | 1 |
| Nilsson, O | 1 |
| Säveland, H | 1 |
| Holtås, S | 1 |
| Larsson, EM | 1 |
| He, HW | 1 |
| Jiang, CH | 1 |
| Liu, HB | 1 |
| Li, YX | 1 |
| Zhang, JB | 1 |
| Wu, ZX | 1 |
| Toulgoat, F | 1 |
| Túlio Salles Rezende, M | 1 |
| Piotin, M | 2 |
| Spelle, L | 2 |
| Lazzarotti, G | 1 |
| Desal, H | 1 |
| Moret, J | 2 |
| Ayad, M | 1 |
| Eskioglu, E | 1 |
| Weber, W | 2 |
| Kis, B | 2 |
| Siekmann, R | 2 |
| Kuehne, D | 1 |
| Benndorf, G | 1 |
| Kessler, I | 1 |
| Herman, TE | 1 |
| Siegel, MJ | 1 |
| Vachharajani, A | 1 |
| Masand, P | 1 |
| Cross, D | 1 |
| Wang, QH | 1 |
| Arat, A | 1 |
| Cil, BE | 1 |
| Vargel, I | 1 |
| Turkbey, B | 1 |
| Canyigit, M | 1 |
| Peynircioglu, B | 1 |
| Arat, YO | 1 |
| Jans, P | 1 |
| Laumer, R | 1 |
| Kühne, D | 1 |
| Lv, M | 1 |
| Zhang, J | 1 |
| Dabus, G | 1 |
| Eskey, CJ | 1 |
| Pryor, JC | 1 |
| Silva, NA | 1 |
| Tall, P | 1 |
| Murugesan, C | 1 |
| Saravanan, S | 1 |
| Rajkumar, J | 1 |
| Prasad, J | 1 |
| Banakal, S | 1 |
| Muralidhar, K | 1 |
| Ziegler, J | 2 |
| Gonzalez, NR | 2 |
| Barbier, C | 1 |
| Legeais, M | 1 |
| Cottier, JP | 1 |
| Bibi, R | 1 |
| Murayama, Y | 2 |
| Ulhoa, A | 1 |
| Akiba, Y | 1 |
| Gobin, YP | 2 |
| Vinters, HV | 2 |
| Greff, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Apollo™ Onyx™ Delivery Microcatheter Post Market Safety Study[NCT02378883] | 112 participants (Actual) | Interventional | 2015-05-18 | Completed | |||
| LIQUID - Treatment of Dural Arteriovenous Fistulas With SQUID™ Liquid Embolic Agent, A Non-interventional, Observational, Prospective and Multi-center Study[NCT03524976] | 50 participants (Actual) | Observational | 2017-01-01 | Completed | |||
| Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations (TATAM): A Randomized Controlled Trial and Registry[NCT03691870] | 76 participants (Anticipated) | Interventional | 2018-08-02 | Recruiting | |||
| Safety of Apollo Embolization Delivery Micro Catheter in Pediatric Patients With Vascular Malformations[NCT02085278] | 10 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with catheter-related adverse events at 12 months (long term secondary endpoint) (NCT02378883)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 68 |
"Premature (unintentional) catheter tip detachment with clinical sequelae~Catheter rupture/break/fracture with clinical sequelae~Retained catheter body in the vasculature" (NCT02378883)
Timeframe: 30 days, after treatment with Onyx™ embolization using Apollo™ Onyx™ Delivery Microcatheter
| Intervention | Participants (Count of Participants) |
|---|---|
| AVM Treatment | 0 |
Incidence of catheter-related adverse events at 30 days (NCT02378883)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 31 |
Rate of catheter/tip leakage from detachment zone (NCT02378883)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 0 |
Rate of intentional catheter tip detachment (NCT02378883)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 68 |
Rate of migration of the retained catheter tip post embolization (long-term secondary endpoint) (NCT02378883)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 0 |
Rate of migration of the retained catheter tip post embolization (NCT02378883)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 0 |
Rate of premature (unintentional) catheter tip detachment (NCT02378883)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| APOLLO | 1 |
11 reviews available for dimethyl sulfoxide and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Delayed Migration of Onyx Embolic Agent after Preoperative Embolization of an Arteriovenous Malformation in a Pediatric Patient: A Case Report and Review of the Literature.
Topics: Cerebral Angiography; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Infant, Newborn; | 2023 |
Embolic Agents and Microcatheters for Endovascular Treatment of Cerebral Arteriovenous Malformations.
Topics: Arteriovenous Fistula; Catheters; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Humans | 2020 |
Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.
Topics: Animals; Central Nervous System Vascular Malformations; Decapodiformes; Dimethyl Sulfoxide; Emboliza | 2022 |
Letter: Comparison of N-butyl Cyanoacrylate and Onyx for the Embolization of Intracranial Arteriovenous Malformations-Analysis of Fluoroscopy and Procedure Times.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Fluoroscopy; Humans; Intracranial Arteri | 2017 |
Onyx® in the management of cranial arteriovenous malformations.
Topics: Dimethyl Sulfoxide; Enbucrilate; Humans; Intracranial Arteriovenous Malformations; Polyvinyls; Ruptu | 2013 |
Embolization-induced angiogenesis in cerebral arteriovenous malformations.
Topics: Antigens, CD; Cell Hypoxia; Cerebrovascular Circulation; Combined Modality Therapy; Dimethyl Sulfoxi | 2014 |
Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis.
Topics: Clinical Trials as Topic; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Humans; Intrac | 2016 |
Endovascular Treatment of Two High-Flow Brain Arteriovenous Fistulas with a Combination of Detachable Coils and Onyx in an Infant: Case Report and Review of Literature.
Topics: Arteriovenous Fistula; Child, Preschool; Dimethyl Sulfoxide; Endovascular Procedures; Humans; Intrac | 2015 |
Advances in interventional neuroradiology.
Topics: Angioplasty; Carotid Artery Diseases; Cerebral Angiography; Clinical Trials as Topic; Dimethyl Sulfo | 2003 |
Liquid embolic agents in the treatment of intracranial arteriovenous malformations.
Topics: Cyanoacrylates; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Ma | 2005 |
Onyx: a unique neuroembolic agent.
Topics: Cerebral Hemorrhage; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arterioveno | 2006 |
15 trials available for dimethyl sulfoxide and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment.
Topics: Adult; Arteriovenous Fistula; Catheters; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Huma | 2020 |
Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas Presenting with Intracranial Hemorrhage in 46 Consecutive Patients: With Emphasis on Transarterial Embolization with Onyx.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hemostatics; Humans; Intracranial Arterioveno | 2016 |
Onyx embolization as a first line treatment for intracranial dural arteriovenous fistulas with cortical venous reflux.
Topics: Adult; Aged; Cerebral Cortex; Cerebral Veins; Cerebrovascular Disorders; Combined Modality Therapy; | 2009 |
Endovascular treatment of brain arteriovenous malformations using onyx: results of a prospective, multicenter study.
Topics: Adolescent; Adult; Angioplasty; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Follow-Up Stu | 2009 |
Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results.
Topics: Adolescent; Adult; Aged; Catheterization; Child; Child, Preschool; Dimethyl Sulfoxide; Embolization, | 2010 |
Periprocedural bleeding complications of brain AVM embolization with Onyx.
Topics: Adolescent; Adult; Cerebral Angiography; Cerebral Hemorrhage; China; Comorbidity; Dimethyl Sulfoxide | 2010 |
A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.
Topics: Adolescent; Adult; Aged; Blood Loss, Surgical; Brain; Child; Combined Modality Therapy; Dimethyl Sul | 2010 |
Treatment of brain arteriovenous malformations by double arterial catheterization with simultaneous injection of Onyx: retrospective series of 17 patients.
Topics: Adolescent; Adult; Balloon Occlusion; Cerebral Arteries; Child; Combined Modality Therapy; Dimethyl | 2011 |
Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results.
Topics: Adolescent; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hemostatics; Humans; | 2012 |
Comment on: Curative Embolization of Brain Arteriovenous Malformations with Onyx: Patient Selection, Embolization Technique, and Results.
Topics: Adolescent; Adult; Aged; Child; Cluster Analysis; Dimethyl Sulfoxide; Embolization, Therapeutic; Fem | 2012 |
Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.
Topics: Adolescent; Adult; Aged; Cerebral Angiography; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; | 2007 |
Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients.
Topics: Adolescent; Adult; Cerebral Angiography; Child; Child, Preschool; Cyanoacrylates; Dimethyl Sulfoxide | 2007 |
Embolization of high-flow craniofacial vascular malformations with onyx.
Topics: Adult; Child; Craniofacial Abnormalities; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hum | 2007 |
Preoperative embolization of intracranial arteriovenous malformations with Onyx.
Topics: Adolescent; Adult; Cerebral Angiography; Child; Combined Modality Therapy; Dimethyl Sulfoxide; Embol | 2007 |
Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx.
Topics: Adult; Aged; Central Nervous System Vascular Malformations; Cerebral Angiography; Cerebral Hemorrhag | 2008 |
109 other studies available for dimethyl sulfoxide and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Rupture of a detachable-tip microcatheter away from the detachment zone during Onyx 18 embolization of an arteriovenous malformation and management of the complication.
Topics: Dimethyl Sulfoxide; Drug Combinations; Embolization, Therapeutic; Humans; Intracranial Arteriovenous | 2022 |
Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Fluoroscopy; Humans; Intracranial Arteriovenous Malfo | 2023 |
Comparative cost analysis of liquid embolization systems for brain arteriovenous malformation using a real-world US hospital database: TRUFILL
Topics: Adult; Brain; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hospitals; Humans; Intracranial | 2023 |
PHIL
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; En | 2022 |
Material-Specific Roadmap Modes Can Improve the Visibility of Liquid Embolic Agents for Endovascular Embolization: A Systematic In Vitro Study.
Topics: Angiography; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malfo | 2022 |
Transvenous embolization for craniocervical junction epidural arteriovenous fistula with a pial feeder aneurysm.
Topics: Aged; Aneurysm, Ruptured; Arteriovenous Fistula; Cerebral Veins; Cervical Atlas; Dimethyl Sulfoxide; | 2020 |
Successfully disposal of an acute MCA occlusion by Onyx during AVM embolism.
Topics: Adolescent; Dimethyl Sulfoxide; Embolism; Embolization, Therapeutic; Female; Humans; Intracranial Ar | 2020 |
First Line Onyx Embolization in Ruptured Pediatric Arteriovenous Malformations : Safety and Efficacy.
Topics: Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial Arteriovenous Mal | 2021 |
Initial Experience in a Pig Model of Robotic-Assisted Intracranial Arteriovenous Malformation (AVM) Embolization.
Topics: Animals; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformat | 2020 |
Transvenous arteriovenous malformation embolization.
Topics: Adult; Arteriovenous Fistula; Cerebral Veins; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; | 2020 |
A Case Series of Ethmoidal Dural Arteriovenous Fistulas Treated by Endovascular Embolization with Onyx.
Topics: Aged; Arteriovenous Fistula; Central Nervous System Vascular Malformations; Cerebral Angiography; Ce | 2020 |
Transvenous Embolization of a Ruptured Arteriovenous Malformation.
Topics: Arteriovenous Fistula; Cerebral Veins; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intrac | 2020 |
Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study.
Topics: Adult; Brain; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial Arterioven | 2021 |
Techniques of Onyx Embolization of Arteriovenous Malformation: 2-Dimensional Operative Video.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial Arteriovenous Malformati | 2021 |
Imaging Artifacts of Nonadhesive Liquid Embolic Agents in Conventional and Cone-beam CT in a Novel in Vitro AVM Model.
Topics: Artifacts; Cone-Beam Computed Tomography; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Int | 2021 |
Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
Topics: Combined Modality Therapy; Dimethyl Sulfoxide; Drug Combinations; Embolization, Therapeutic; Endovas | 2017 |
Curative and adjunctive AVM Onyx embolization of AVMs through the choroidal arteries.
Topics: Adolescent; Adult; Cerebral Angiography; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Femal | 2017 |
Mechanical removal of a refluxed Onyx piece from the middle cerebral artery using the Solitaire Stent: Technical report.
Topics: Angiography, Digital Subtraction; Cerebral Angiography; Dimethyl Sulfoxide; Embolization, Therapeuti | 2017 |
A challenging entity of endovascular embolization with ONYX for brainstem arteriovenous malformation: Experience from 13 cases.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Brain Stem; Cerebral Angiography; Child; Combin | 2017 |
Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Drug Evaluation, Preclinical; Embolization, The | 2018 |
Onyx embolization prior to stereotactic radiosurgery for brain arteriovenous malformations: a single-center treatment algorithm.
Topics: Adult; Algorithms; Brain; Combined Modality Therapy; Dimethyl Sulfoxide; Embolization, Therapeutic; | 2018 |
Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriovenous Fistula; Catheterization; Catheters; Child | 2018 |
Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM.
Topics: Adolescent; Child; Cohort Studies; Combined Modality Therapy; Dimethyl Sulfoxide; Embolization, Ther | 2018 |
Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Cerebral Angiography; Child; Dimethyl Sulfoxide | 2019 |
Seizure predictors and outcome after Onyx embolization in patients with brain arteriovenous malformations.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Cerebral Angiography; Child; Child, Preschool; | 2019 |
Transarterial Onyx Embolization of Residual Arteriovenous Malformation After Surgical Resection.
Topics: Adolescent; Adult; Arteriovenous Fistula; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Fema | 2019 |
Staged transarterial endovascular embolization of a malignant dural arteriovenous fistula using Onyx and n-butyl cyanoacrylate.
Topics: Aged; Central Nervous System Vascular Malformations; Cerebral Angiography; Cyanoacrylates; Dimethyl | 2019 |
Transitory brain stem edema following successfully transvenous embolization of a posterior fossa arteriovenous malformation.
Topics: Brain Edema; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malfo | 2014 |
Transvenous Onyx embolization of a subependymal deep arteriovenous malformation with a single drainage vein: technical note.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Ependyma; Female; Humans; Intracranial Arteriovenous | 2013 |
Endovascular treatment of deep hemorrhagic brain arteriovenous malformations with transvenous onyx embolization.
Topics: Adult; Cerebral Hemorrhage; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Endovascular Proce | 2013 |
[A new method for distant Onyx injection for treatment of intracranial arteriovenous malformations: report of 26 cases].
Topics: Adolescent; Adult; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intra | 2013 |
Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriovenous Fistula; Dimethyl Sulfoxide; Embolization, | 2013 |
Endovascular embolization of cerebral arteriovenous malformations: results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cerebral Hemorrhage; Child; Child, Preschool | 2014 |
The pressure cooker technique for the treatment of brain AVMs.
Topics: Adult; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Equipment Design; Equipment Failu | 2014 |
Direct continuous measurement of draining vein pressure during Onyx embolization in a swine arteriovenous malformation model.
Topics: Animals; Blood Pressure; Cerebral Veins; Dimethyl Sulfoxide; Disease Models, Animal; Embolization, T | 2015 |
Transvenous Onyx embolization of a subependymal deep arteriovenous malformation with a single drainage vein: technical note.
Topics: Cerebral Veins; Dimethyl Sulfoxide; Embolization, Therapeutic; Ependyma; Female; Humans; Intracrania | 2014 |
Balloon-augmented Onyx embolization of cerebral arteriovenous malformations using a dual-lumen balloon: a multicenter experience.
Topics: Balloon Occlusion; Dimethyl Sulfoxide; Fluoroscopy; Humans; Intracranial Arteriovenous Malformations | 2015 |
Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Combined Modality Therapy; | 2015 |
Transarterial Onyx Embolization for Patients with Cavernous Sinus Dural Arteriovenous Fistulas Who Have Failed Transvenous Embolization.
Topics: Adult; Arteriovenous Fistula; Cavernous Sinus; Cerebral Angiography; Dimethyl Sulfoxide; Embolizatio | 2015 |
Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriovenous Fistula; Child; Child, Preschool; Dimethyl | 2015 |
Editorial: Arteriovenous malformations and embolization.
Topics: Arteriovenous Fistula; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial A | 2015 |
Mechanical Removal of Migrated Onyx Due to Microcatheter Rupture During AVM Embolization: A Technical Case Report.
Topics: Aged; Catheters; Dimethyl Sulfoxide; Embolization, Therapeutic; Equipment Failure; Foreign-Body Migr | 2015 |
Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
Topics: Cardiovascular Agents; Central Nervous System Vascular Malformations; Dimethyl Sulfoxide; Embolizati | 2016 |
Onyx resorbtion with AVM recanalization after complete AVM obliteration.
Topics: Angiography, Digital Subtraction; Cerebral Angiography; Child; Dimethyl Sulfoxide; Embolization, The | 2015 |
Multimodality intraoperative neurophysiological monitoring during Onyx embolization of cerebrovascular malformations.
Topics: Adult; Anesthesia, Intravenous; Dimethyl Sulfoxide; Electroencephalography; Embolization, Therapeuti | 2015 |
Response.
Topics: Arteriovenous Fistula; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial A | 2015 |
Letter to the Editor: Stereotactic radiosurgery for AVMs with and without Onyx embolization.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial Arteriovenous Malformati | 2015 |
Predictive Factors for Response of Intracranial Dural Arteriovenous Fistulas to Transarterial Onyx Embolization: Angiographic Subgroup Analysis of Treatment Outcomes.
Topics: Aged; Aged, 80 and over; Angiography; Arteriovenous Fistula; Dimethyl Sulfoxide; Embolization, Thera | 2016 |
De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.
Topics: Age of Onset; Arteriovenous Fistula; Child, Preschool; Dimethyl Sulfoxide; Embolization, Therapeutic | 2016 |
Curative embolization of pediatric intracranial arteriovenous malformations using Onyx: the role of new embolization techniques on patient outcomes.
Topics: Adolescent; Cerebral Angiography; Child; Child, Preschool; Computed Tomography Angiography; Dimethyl | 2016 |
Modified pressure cooker technique: An easier way to control onyx reflux.
Topics: Adult; Aged; Central Nervous System Vascular Malformations; Dimethyl Sulfoxide; Embolization, Therap | 2016 |
Less can be more: Targeted embolization of aneurysms associated with arteriovenous malformations unsuitable for surgical resection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Cerebral Angiography; Child; Child, | 2016 |
Onyx extravasation during embolization of a brain arteriovenous malformation.
Topics: Adult; Dimethyl Sulfoxide; Embolization, Therapeutic; Extravasation of Diagnostic and Therapeutic Ma | 2017 |
The transvenous pressure cooker technique: A treatment for brain arteriovenous malformations.
Topics: Angiography, Digital Subtraction; Dimethyl Sulfoxide; Drainage; Endovascular Procedures; Female; Hum | 2017 |
Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
Topics: Adult; Aged; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracranial Arterioveno | 2017 |
A Case Report of Onyx Pulmonary Arterial Embolism Contributing to Hypoxemia During Awake Craniotomy for Arteriovenous Malformation Resection.
Topics: Adult; Computed Tomography Angiography; Craniotomy; Dimethyl Sulfoxide; Embolization, Therapeutic; E | 2017 |
Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times.
Topics: Adult; Cohort Studies; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Female; Fluorosco | 2008 |
Treatment of pediatric intracranial vascular malformations using Onyx-18.
Topics: Brain; Child; Dimethyl Sulfoxide; Electroencephalography; Embolization, Therapeutic; Female; Humans; | 2008 |
Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances.
Topics: Cohort Studies; Combined Modality Therapy; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hu | 2008 |
Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; H | 2009 |
[Transarterial embolization of intracranial dural arteriovenous malformations with ethylene vinyl alcohol copolymer (Onyx18): report of three cases].
Topics: Cerebral Angiography; Dimethyl Sulfoxide; Dura Mater; Embolization, Therapeutic; Female; Humans; Int | 2008 |
Embolization of brain arteriovenous malformations for cure: because we could or because we should?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; H | 2009 |
Preoperative embolization of cerebral arteriovenous malformations with onyx.
Topics: Adolescent; Adult; Combined Modality Therapy; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; | 2009 |
[Therapeutic effect of embolization of brain arteriovenous malformation with non-adhesive liquid embolic agent].
Topics: Adolescent; Adult; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Follow-Up Stu | 2008 |
Embolization of brain arteriovenous malformations for cure: because we could and because we should.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; H | 2009 |
Balloon-assisted transarterial embolization of intracranial dural arteriovenous fistulas.
Topics: Aged; Balloon Occlusion; Dimethyl Sulfoxide; Dura Mater; Female; Humans; Intracranial Arteriovenous | 2009 |
Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.
Topics: Brain Infarction; Cerebral Hemorrhage; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; G | 2009 |
Time-of-flight magnetic resonance angiography imaging of a residual arteriovenous malformation nidus after Onyx embolization for stereotactic radiosurgery planning. Technical note.
Topics: Adult; Artifacts; Basilar Artery; Brain Stem; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; | 2009 |
Desaturation during Onyx embolization for intracranial arteriovenous malformations.
Topics: Adolescent; Adult; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intra | 2009 |
Resolution of trigeminal neuralgia following cerebellar AVM embolization with Onyx.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformations; Mal | 2009 |
Retrograde venonidal microsurgical obliteration of brain stem AVM: a clinical feasibility study.
Topics: Aged; Brain Stem; Cerebral Angiography; Cerebral Veins; Dimethyl Sulfoxide; Embolization, Therapeuti | 2009 |
Use of Onyx (a patented ethylene-vinyl alcohol copolymer formulation) embolisation of cerebral arteriovenous malformations in Hong Kong: initial experience.
Topics: Adolescent; Adult; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Hong Kong; Humans; Intracr | 2009 |
Endovascular treatment of congenital brain arteriovenous fistulas with combination of detachable coils and onyx liquid embolic agent.
Topics: Adolescent; Adult; Arteriovenous Fistula; Child; Child, Preschool; Combined Modality Therapy; Dimeth | 2010 |
Editorial. Onyx embolization of arteriovenous malformations.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Humans; Intracranial Arteriovenous Malfo | 2010 |
Desaturation during Onyx embolization.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; | 2010 |
Onyx embolization for the treatment of brain arteriovenous malformations.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Child; Combined Modality Therapy; Dimethyl Sulf | 2011 |
Endovascular treatment of cerebral aneurysms associated with arteriovenous malformations.
Topics: Adolescent; Adult; Aged; Cerebral Angiography; Child; Child, Preschool; Dimethyl Sulfoxide; Emboliza | 2012 |
Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Humans; Intracranial Arteriovenous Malfo | 2011 |
Microsurgical retrieval of an endovascular microcatheter trapped during Onyx embolization of a cerebral arteriovenous malformation.
Topics: Catheterization; Cerebral Hemorrhage; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; | 2011 |
Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation.
Topics: Adult; Brain Edema; Dimethyl Sulfoxide; Embolization, Therapeutic; Epilepsy; Female; Humans; Intracr | 2011 |
Onyx embolization of an extensive mandibular arteriovenous malformation via a dual lumen balloon catheter: a technical case report.
Topics: Adolescent; Catheterization; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intracra | 2013 |
Endovascular treatment of ruptured brain AVMs in the acute phase of hemorrhage.
Topics: Acute Disease; Adolescent; Adult; Aged; Cerebral Hemorrhage; Child; Dimethyl Sulfoxide; Embolization | 2012 |
ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Vascular Malformations; Cohort Studies; Dimet | 2013 |
Flow control techniques for Onyx embolization of intracranial dural arteriovenous fistulae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Blood Flow Velocity; C | 2013 |
Management of brain AVM procedural hemorrhagic complication by the "security" catheter technique.
Topics: Catheterization; Cerebral Hemorrhage; Child; Dimethyl Sulfoxide; Female; Hemostatics; Humans; Intrac | 2013 |
Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation.
Topics: Adult; Arteriovenous Fistula; Dimethyl Sulfoxide; Embolization, Therapeutic; Enbucrilate; Endovascul | 2012 |
Transarterial balloon assisted Onyx embolization of pericallosal arteriovenous malformations.
Topics: Adult; Balloon Occlusion; Cerebral Arteries; Corpus Callosum; Dimethyl Sulfoxide; Embolization, Ther | 2013 |
[Elective cerebral arteriovenous malformation treatment with onyx after coil embolization of ruptured, flow-realeted aneurysm of the posterior circulation].
Topics: Adult; Aneurysm, Ruptured; Cerebral Angiography; Dimethyl Sulfoxide; Elective Surgical Procedures; E | 2012 |
Dynamic contrast-enhanced MRA at 1.5 T for detection of arteriovenous shunting before and after Onyx embolization of cerebral arteriovenous malformations.
Topics: Adult; Contrast Media; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Gadolinium DTPA; Hemos | 2013 |
Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery.
Topics: Adolescent; Adult; Angiography, Digital Subtraction; Aphasia; Child; Child, Preschool; Combined Moda | 2013 |
Onyx embolization of intracranial arteriovenous malformations in pediatric patients.
Topics: Adolescent; Age Factors; Arteriovenous Fistula; Child; Child, Preschool; Dimethyl Sulfoxide; Emboliz | 2013 |
Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformations; Pol | 2002 |
Onyx in treatment of large and giant cerebral aneurysms and arteriovenous malformations.
Topics: Adolescent; Adult; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intra | 2004 |
Arteriovenous malformations of the brain: ready to randomise?
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenous Malformations; Neu | 2005 |
Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging.
Topics: Adult; Angioplasty; Diffusion Magnetic Resonance Imaging; Dimethyl Sulfoxide; DNA-Binding Proteins; | 2006 |
Endovascular treatment of cerebral arteriovenous malformations with Onyx embolization.
Topics: Adolescent; Adult; Aged; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Humans; Intra | 2005 |
[Transarterial embolisation of intracranial dural arteriovenous malformations with ethylene vinyl alcohol copolymer (Onyx18)].
Topics: Aged; Cerebral Angiography; Dimethyl Sulfoxide; Dura Mater; Embolization, Therapeutic; Female; Human | 2006 |
Brain AVM embolization with Onyx.
Topics: Adolescent; Adult; Aged; Arteriovenous Fistula; Cerebral Angiography; Cerebral Hemorrhage; Dimethyl | 2007 |
Cerebral arteriovenous fistula to pulmonary artery onyx embolization.
Topics: Adult; Arteriovenous Fistula; Cerebral Arteries; Dimethyl Sulfoxide; Embolization, Therapeutic; Fata | 2007 |
[Clinical experience of 70 cases of cerebral arteriovenous malformations embolization with Onyx, a novel liquid embolic agent].
Topics: Adolescent; Adult; Child; Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Follow-Up Studies; | 2007 |
Trigeminocardiac reflex in embolization of intracranial dural arteriovenous fistula.
Topics: Bradycardia; Central Nervous System Vascular Malformations; Dimethyl Sulfoxide; Embolization, Therap | 2007 |
Preliminary experience with onyx embolization for the treatment of intracranial dural arteriovenous fistulas.
Topics: Dimethyl Sulfoxide; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Intracranial Art | 2008 |
Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation.
Topics: Adult; Angioplasty; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; Intracranial Arteriovenou | 2008 |
Transarterial embolization of clival dural arteriovenous fistulae using liquid embolic agents.
Topics: Aged; Aged, 80 and over; Cavernous Sinus; Cerebral Angiography; Cranial Fossa, Posterior; Cyanoacryl | 2008 |
Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients.
Topics: Adolescent; Adult; Aged; Angioplasty; Cohort Studies; Dimethyl Sulfoxide; Embolization, Therapeutic; | 2008 |
Combined covered stent and onyx treatment for complex dural arteriovenous fistula involving the clivus and cavernous sinus.
Topics: Cavernous Sinus; Cranial Fossa, Posterior; Dimethyl Sulfoxide; Embolization, Therapeutic; Humans; In | 2009 |
[Failure of transverse sinus dural fistula embolization using ethanol injection].
Topics: Cerebral Angiography; Cranial Sinuses; Dimethyl Sulfoxide; Dura Mater; Embolization, Therapeutic; En | 2008 |
Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.
Topics: Animals; Biocompatible Materials; Dimethyl Sulfoxide; Disease Models, Animal; Embolization, Therapeu | 1998 |
Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients.
Topics: Adult; Aged; Brain Ischemia; Cerebral Angiography; Dimethyl Sulfoxide; Diplopia; Embolization, Thera | 2001 |